CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 52 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $816,000 | -32.2% | 150,000 | -62.5% | 0.03% | -45.8% |
| Q3 2019 | $1,204,000 | -19.5% | 400,000 | 0.0% | 0.05% | -11.1% |
| Q2 2019 | $1,496,000 | -7.0% | 400,000 | 0.0% | 0.05% | -12.9% |
| Q1 2019 | $1,608,000 | +9.5% | 400,000 | 0.0% | 0.06% | -10.1% |
| Q4 2018 | $1,468,000 | -70.2% | 400,000 | -30.4% | 0.07% | -61.5% |
| Q3 2018 | $4,934,000 | -21.9% | 575,000 | 0.0% | 0.18% | -26.3% |
| Q2 2018 | $6,314,000 | -4.8% | 575,000 | 0.0% | 0.24% | -14.1% |
| Q1 2018 | $6,630,000 | +51.4% | 575,000 | +36.1% | 0.28% | +42.2% |
| Q4 2017 | $4,378,000 | -35.0% | 422,600 | 0.0% | 0.20% | -36.0% |
| Q3 2017 | $6,736,000 | +31.7% | 422,600 | 0.0% | 0.31% | +20.5% |
| Q2 2017 | $5,113,000 | -41.7% | 422,600 | 0.0% | 0.26% | -49.0% |
| Q1 2017 | $8,777,000 | +36.4% | 422,600 | -6.1% | 0.51% | +17.4% |
| Q4 2016 | $6,435,000 | -13.1% | 450,000 | 0.0% | 0.43% | -7.1% |
| Q3 2016 | $7,403,000 | +15.4% | 450,000 | 0.0% | 0.46% | -2.3% |
| Q2 2016 | $6,417,000 | -3.1% | 450,000 | -1.5% | 0.48% | -14.4% |
| Q1 2016 | $6,625,000 | – | 456,887 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $11,661,000 | 2.42% |
| Telemetry Investments, L.L.C. | 189,081 | $673,000 | 1.14% |
| CHI Advisors LLC | 490,877 | $1,748,000 | 0.49% |
| BVF INC/IL | 1,943,712 | $6,920,000 | 0.27% |
| Orbimed Advisors | 6,767,584 | $24,093,000 | 0.21% |
| Novo Holdings A/S | 847,906 | $3,019,000 | 0.13% |
| Golden Green, Inc. | 19,539 | $70,000 | 0.06% |
| ALGERT GLOBAL LLC | 15,467 | $55,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,700 | $476,000 | 0.01% |
| Hikari Power Ltd | 19,959 | $71,000 | 0.01% |